Patient preferences for reducing bowel adverse events following prostate radiotherapy. by Mark V Mishra, Winter Maxwell Thayer, Ellen Janssen, Bradford Hoppe, Caitlin Eggleston, John F P Bridges

Get full text

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415. by Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, W Robert Lee, Ester Villalonga Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M Bentzen, Amit B Shah, Shawn C Malone, Jeff M Michalski, Ian S Dayes, Samantha A Seaward, Michele Albert, Adam D Currey, Thomas M Pisansky, Yuhchyau Chen, Eric M Horwitz, Albert S DeNittis, Felix Y Feng, Mark V Mishra

Get full text

Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort Study by Roshan S. Prabhu, MD, MS, Rachel Russek, MPH, Zachary K. Vaslow, MD, Jennifer K. Matsui, PhD, Neda Haghighi, MD, Tu Dan, MD, Mark V. Mishra, MD, Erin S. Murphy, MD, Susan Boyles, RTT, Haley K. Perlow, MD, Joshua D. Palmer, MD, Cristian Udovicich, MD, Toral R. Patel, MD, Zabi Wardak, MD, Graeme F. Woodworth, MD, Alexander Ksendzovsky, MD, PhD, Kailin Yang, MD, PhD, Samuel T. Chao, MD, Anthony L. Asher, MD, Stuart H. Burri, MD

Get full text